Geisinger South Wilkes-Barre — Wilkes-Barre, Pennsylvania

Geisinger South Wilkes-Barre is a clinical research site located in Wilkes-Barre, Pennsylvania, United States 18765.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Geisinger South Wilkes-Barre has participated in 9 clinical trials with 4 currently active.

Therapeutic areas: Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, Geisinger Clinic.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Geisinger South Wilkes-Barre?

Geisinger South Wilkes-Barre has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Geisinger South Wilkes-Barre conducted?

Geisinger South Wilkes-Barre has 9 clinical trials on record, with 4 currently active. Their work covers Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia.

Is Geisinger South Wilkes-Barre accredited by Crixeo Health?

Yes — Geisinger South Wilkes-Barre holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Geisinger South Wilkes-Barre?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.